ADVERTISEMENT
ADVERTISEMENT
Major win: Bhattacharya on NIH hypertension clinical trial
Intervention costing about $760 per patient shows potential to cut cardiovascular events and ease provider burden.
-
Malvika Choudhary - Sat, 18, Apr 2026
- 17:25 EDT
- 27
.JPG)
U.S. National Institutes of Health (NIH) Director Jay Bhattacharya testifies before a Senate Appropriations Committee hearing on U.S. President Donald Trump's budget request for the NIH, on Capitol Hill in Washington, D.C., U.S., June 10, 2025. / REUTERS/Kent Nishimura
National Institutes of Health Director Jay Bhattacharya on April 18 called an NIH-supported clinical trial a “major win” after it showed that a low-cost, team-based care model can significantly reduce high blood pressure in high-risk patients.
“Major win in the fight against chronic disease. A simple, team-based care model significantly reduced high blood pressure in high-risk patients,” Bhattacharya said in a post on X, adding that the approach led to “big drops in blood pressure – fewer heart attacks, fewer strokes, and healthier American lives.”
Als0 Read: NIH focusing on women’s health research, says Bhattacharya
This post is for paying subscribers only
SUBSCRIBE NOWRelated
.png)
.png)
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login